Skip to main content
. 2007 May 16;110(7):2620–2630. doi: 10.1182/blood-2006-11-059139

Table 1.

Evaluation of CAR receptor expression on EBV-CTL after stimulation with EBV+ and CD30+ tumor cells

CD30CAR+ cells Stimulation
Second Third Fourth
After stimulation with EBV+ tumor cells 19 ± 10 23.8 ± 5 16.8 ± 8
After stimulation with CD30+ tumor cells 18.2 ± 14 26.4 ± 10 21 ± 11

Data are percentages of CD30CAR+ cells. Evaluation was of CD30CAR expression on transduced CTLs after the indicated stimulation with autologous LCLs or CD30+ tumor cells. Analysis was performed by FACS after staining with antihuman IgG (H+L) Ab.